WORX Quote, Financials, Valuation and Earnings

CVS Health Corp. has a net margin of -185.96% compared to SCWorx Corp.'s net margin of -3.88%. SCWorx Corp.'s return on equity of -74.77% beat CVS Health Corp.'s return on equity of 0.57%.

SCWorx Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand CVS Health Corp. has an analysts' consensus of $94.33 which suggests that it could grow by 18.47%. Given that CVS Health Corp. has higher upside potential than SCWorx Corp., analysts believe CVS Health Corp. is more attractive than SCWorx Corp..

SCWorx Corp. has a beta of 1.922, which suggesting that the stock is 92.248% more volatile than S&P 500. In comparison CVS Health Corp. has a beta of 0.481, suggesting its less volatile than the S&P 500 by 51.936%.

SCWorx Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CVS Health Corp. offers a yield of 3.33% to investors and pays a quarterly dividend of $0.67 per share. SCWorx Corp. pays -- of its earnings as a dividend. CVS Health Corp. pays out 72.76% of its earnings as a dividend. CVS Health Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

SCWorx Corp. quarterly revenues are $705.8K, which are smaller than CVS Health Corp. quarterly revenues of $102.9B. SCWorx Corp.'s net income of -$1.3M is higher than CVS Health Corp.'s net income of -$4B. Notably, SCWorx Corp.'s price-to-earnings ratio is -- while CVS Health Corp.'s PE ratio is 208.70x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SCWorx Corp. is 0.29x versus 0.26x for CVS Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.

First Physicians Capital Group, Inc. has a net margin of -185.96% compared to SCWorx Corp.'s net margin of --. SCWorx Corp.'s return on equity of -74.77% beat First Physicians Capital Group, Inc.'s return on equity of --.

SCWorx Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand First Physicians Capital Group, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that SCWorx Corp. has higher upside potential than First Physicians Capital Group, Inc., analysts believe SCWorx Corp. is more attractive than First Physicians Capital Group, Inc..

SCWorx Corp. has a beta of 1.922, which suggesting that the stock is 92.248% more volatile than S&P 500. In comparison First Physicians Capital Group, Inc. has a beta of 0.538, suggesting its less volatile than the S&P 500 by 46.195%.

SCWorx Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. First Physicians Capital Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SCWorx Corp. pays -- of its earnings as a dividend. First Physicians Capital Group, Inc. pays out -- of its earnings as a dividend.

SCWorx Corp. quarterly revenues are $705.8K, which are larger than First Physicians Capital Group, Inc. quarterly revenues of --. SCWorx Corp.'s net income of -$1.3M is higher than First Physicians Capital Group, Inc.'s net income of --. Notably, SCWorx Corp.'s price-to-earnings ratio is -- while First Physicians Capital Group, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SCWorx Corp. is 0.29x versus 1.42x for First Physicians Capital Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

IQVIA Holdings, Inc. has a net margin of -185.96% compared to SCWorx Corp.'s net margin of 8.1%. SCWorx Corp.'s return on equity of -74.77% beat IQVIA Holdings, Inc.'s return on equity of 20.65%.

SCWorx Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand IQVIA Holdings, Inc. has an analysts' consensus of $253.95 which suggests that it could grow by 11.53%. Given that IQVIA Holdings, Inc. has higher upside potential than SCWorx Corp., analysts believe IQVIA Holdings, Inc. is more attractive than SCWorx Corp..

SCWorx Corp. has a beta of 1.922, which suggesting that the stock is 92.248% more volatile than S&P 500. In comparison IQVIA Holdings, Inc. has a beta of 1.366, suggesting its more volatile than the S&P 500 by 36.638%.

SCWorx Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IQVIA Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SCWorx Corp. pays -- of its earnings as a dividend. IQVIA Holdings, Inc. pays out -- of its earnings as a dividend.

SCWorx Corp. quarterly revenues are $705.8K, which are smaller than IQVIA Holdings, Inc. quarterly revenues of $4.1B. SCWorx Corp.'s net income of -$1.3M is lower than IQVIA Holdings, Inc.'s net income of $332M. Notably, SCWorx Corp.'s price-to-earnings ratio is -- while IQVIA Holdings, Inc.'s PE ratio is 31.26x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SCWorx Corp. is 0.29x versus 2.52x for IQVIA Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

UNIVEC has a net margin of -185.96% compared to SCWorx Corp.'s net margin of --. SCWorx Corp.'s return on equity of -74.77% beat UNIVEC's return on equity of --.

SCWorx Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand UNIVEC has an analysts' consensus of -- which suggests that it could fall by --. Given that SCWorx Corp. has higher upside potential than UNIVEC, analysts believe SCWorx Corp. is more attractive than UNIVEC.

SCWorx Corp. has a beta of 1.922, which suggesting that the stock is 92.248% more volatile than S&P 500. In comparison UNIVEC has a beta of -0.101, suggesting its less volatile than the S&P 500 by 110.112%.

SCWorx Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UNIVEC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SCWorx Corp. pays -- of its earnings as a dividend. UNIVEC pays out -- of its earnings as a dividend.

SCWorx Corp. quarterly revenues are $705.8K, which are larger than UNIVEC quarterly revenues of --. SCWorx Corp.'s net income of -$1.3M is higher than UNIVEC's net income of --. Notably, SCWorx Corp.'s price-to-earnings ratio is -- while UNIVEC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SCWorx Corp. is 0.29x versus -- for UNIVEC. Usually stocks with elevated PS ratios are considered overvalued.